false

Scott Marshall, PhD

Industry authority on precision medicine-guided strategy and development, particularly in translational informatics, data science, and software development operations. Pioneer in SaaS management of complex streams of associated biomarker data and clinical sample inventories. Strategist across a variety of data-centric spaces, including development of complex biomarker signatures for use in patient selection.

• Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Translational Research

  Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Sep 14, ‘26 | 3 min read

  • 

    Christie Bongel

  Discover
• Read: Has the rest of the world finally caught up with Latin America?

  Clinical Trials

  Has the rest of the world finally caught up with Latin America?

  Sep 02, ‘26 | 5 min read

  • 

    Andrés Bayona

  Discover
• Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Translational Research - Assays

  Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Aug 20, ‘26 | 7 min read

  • 

  • Christie B.

    Kennon D.

  Discover
• Read: Clinical AI at Scale: Why Trust Matters More Than Speed

  Clinical Trials

  Clinical AI at Scale: Why Trust Matters More Than Speed

  Aug 18, ‘26 | 6 min read

  • 

  • Zulfat K.

    Shakila J.

    Sugumaran M.

  Discover
• Read: Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Clinical Trials

  Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Aug 17, ‘26 | 5 min read

  • 

    Romy Kane

  Discover
• Read: Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Early Phase Research - Autoimmune

  Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Aug 10, ‘26 | 6 min read

  • 

    Rui F Duarte-Lopes

  Discover
• Read: Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Clinical Trials - Regulatory

  Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Aug 03, ‘26 | 9 min read

  • 

    Harpreet Singh, MD

  Discover
• Read: Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors

  Clinical Trials

  Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors

  Aug 03, ‘26 | 10 min read

  • 

    Deana Demjen

  Discover
• Read: Receptor Occupancy in the Era of Multispecific Therapeutics

  Translational Research - Lab Services

  Receptor Occupancy in the Era of Multispecific Therapeutics

  Jul 28, ‘26 | 6 min read

  • 

  • Deborah P.

    Jenny Z.

  Discover

Loading...

You've reach the end Back to top